Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1978 Sep;75(9):4120–4124. doi: 10.1073/pnas.75.9.4120

Modification of DNA by aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine.

A D D'Andrea, W A Haseltine
PMCID: PMC336063  PMID: 30083

Abstract

The damage to DNA by the hepatocarcinogen aflatoxin B1 was investigated. A DNA fragment of known sequence of the lactose promoter-operator region was used as a substrate for modification by aflatoxin B1. The DNA was incubated with aflatoxin B1 in crude mammalian liver extracts or with purified microsomes. Treatment of the DNA incubated in the complete system with either 1 M piperidine or 0.1 M NaOH at 90 degrees revealed alkali-labile lesions in the DNA. The exact location of the cleavage site was determined by comparison of the length of the cleavage products with the known sequence on polyacrylamide gels. The lengths of the cleavage products were the same as those produced by alkali-induced breakage of the same sequence of DNA that had been modified with dimethyl sulfate. The major cleavage products of the aflatoxin B1-modified DNA were at positions of guanine and the minor cleavage products were at positions of adenine. These studies show that modification of DNA by aflatoxin B1 creates alkali-labile sites at positions of guanine and, to a lesser extent, adenine.

Full text

PDF
4120

Images in this article

4122Image
on p.4122
4123Image
on p.4123
4123Image
on p.4123
4123Image
on p.4123

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Durston W. E., Yamasaki E., Lee F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2281–2285. doi: 10.1073/pnas.70.8.2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arditti R. R., Scaife J. G., Beckwith J. R. The nature of mutants in the lac promoter region. J Mol Biol. 1968 Dec;38(3):421–426. doi: 10.1016/0022-2836(68)90396-3. [DOI] [PubMed] [Google Scholar]
  3. Campbell T. C., Hayes J. R. The role of aflatoxin metabolism in its toxic lesion. Toxicol Appl Pharmacol. 1976 Feb;35(2):199–222. doi: 10.1016/0041-008x(76)90282-9. [DOI] [PubMed] [Google Scholar]
  4. Essigmann J. M., Croy R. G., Nadzan A. M., Busby W. F., Jr, Reinhold V. N., Büchi G., Wogan G. N. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci U S A. 1977 May;74(5):1870–1874. doi: 10.1073/pnas.74.5.1870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garner R. C., Miller E. C., Miller J. A., Garner J. V., Hanson R. S. Formation of a factor lethal for S. typhimurium TA1530 and TA1531 on incubation of aflatoxin B 1 with rat liver microsomes. Biochem Biophys Res Commun. 1971 Nov 5;45(3):774–780. doi: 10.1016/0006-291x(71)90484-0. [DOI] [PubMed] [Google Scholar]
  6. Garner R. C., Miller E. C., Miller J. A. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res. 1972 Oct;32(10):2058–2066. [PubMed] [Google Scholar]
  7. Garner R. C. Reduction in binding of [14C] aflatoxin B1 to rat liver macromolecules by phenobarbitone pretreatment. Biochem Pharmacol. 1975 Aug 15;24(16):1553–1556. doi: 10.1016/0006-2952(75)90039-8. [DOI] [PubMed] [Google Scholar]
  8. Garner R. C., Wright C. M. Binding of [-14C]aflatoxin B1 to cellular macromolecules in the rat and hamster. Chem Biol Interact. 1975 Aug;11(2):121–131. doi: 10.1016/0009-2797(75)90019-8. [DOI] [PubMed] [Google Scholar]
  9. Garner R. C., Wright C. M. Induction of mutations in DNA-repair deficient bacteria by a liver microsomal metabolite of aflatoxin B1. Br J Cancer. 1973 Dec;28(6):544–551. doi: 10.1038/bjc.1973.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gilbert W., Maxam A. The nucleotide sequence of the lac operator. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3581–3584. doi: 10.1073/pnas.70.12.3581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kinoshita N., Shears B., Gelboin H. V. K-region and non-K-region metabolism of benzo(a)pyrene by rat liver microsomes. Cancer Res. 1973 Aug;33(8):1937–1944. [PubMed] [Google Scholar]
  12. Lin J. K., Miller J. A., Miller E. C. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 1977 Dec;37(12):4430–4438. [PubMed] [Google Scholar]
  13. Maizels N. M. The nucleotide sequence of the lactose messenger ribonucleic acid transcribed from the UV5 promoter mutant of Escherichia coli. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3585–3589. doi: 10.1073/pnas.70.12.3585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Maxam A. M., Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977 Feb;74(2):560–564. doi: 10.1073/pnas.74.2.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McCann J., Choi E., Yamasaki E., Ames B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5135–5139. doi: 10.1073/pnas.72.12.5135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McCann J., Spingarn N. E., Kobori J., Ames B. N. Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. Proc Natl Acad Sci U S A. 1975 Mar;72(3):979–983. doi: 10.1073/pnas.72.3.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schoenhard G. L., Lee D. J., Howell S. E., Pawlowski N. E., Libbey L. M., Sinnhuber R. O. Aflatoxin B1 metabolism to aflatoxicol and derivatives lethal to Bacillus subtilis GSY 1057 by rainbow trout (Salmo gairdneri) liver. Cancer Res. 1976 Jun;36(6):2040–2045. [PubMed] [Google Scholar]
  18. Singer B. The chemical effects of nucleic acid alkylation and their relation to mutagenesis and carcinogenesis. Prog Nucleic Acid Res Mol Biol. 1975;15(0):219–284. [PubMed] [Google Scholar]
  19. Swenson D. H., Lin J. K., Miller E. C., Miller J. A. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res. 1977 Jan;37(1):172–181. [PubMed] [Google Scholar]
  20. Swenson D. H., Miller E. C., Miller J. A. Aflatoxin B1-2,3-oxide: evidence for its formation in rat liver in vivo and by human liver microsomes in vitro. Biochem Biophys Res Commun. 1974 Oct 8;60(3):1036–1043. doi: 10.1016/0006-291x(74)90417-3. [DOI] [PubMed] [Google Scholar]
  21. Swenson D. H., Miller J. A., Miller E. C. 2,3-Dihydro-2,3-dihydroxy-aflatoxin B1: an acid hydrolysis product of an RNA-aflatoxin B1 adduct formed by hamster and rat liver microsomes in vitro. Biochem Biophys Res Commun. 1973 Aug 21;53(4):1260–1267. doi: 10.1016/0006-291x(73)90601-3. [DOI] [PubMed] [Google Scholar]
  22. Swenson D. H., Miller J. A., Miller E. C. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1. Cancer Res. 1975 Dec;35(12):3811–3823. [PubMed] [Google Scholar]
  23. Tanaka T., Weisblum B. Construction of a colicin E1-R factor composite plasmid in vitro: means for amplification of deoxyribonucleic acid. J Bacteriol. 1975 Jan;121(1):354–362. doi: 10.1128/jb.121.1.354-362.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES